Literature DB >> 33580460

Role of p53 in transcriptional repression of SVCT2.

Eun Ho Kim1,2, Dong-In Koh1, Yea Seong Ryu1,2, Sang-Soo Park1,2, Seung-Woo Hong1, Jai-Hee Moon1, Jae-Sik Shin1, Mi Jin Kim1,3, Do Yeon Kim1,2, Jun Ki Hong1,2, Hong-Rae Jeong1,2, Hyeseon Yun1,2, Joo-Yeon Shin1,2, Joseph Kim1,2, Yoon Sun Park1,2, Dong Min Kim1,3, Dong-Hoon Jin4,5,6.   

Abstract

SVCT2, Sodium-dependent Vitamin C Transporter 2, uniquely transports ascorbic acid (also known as vitamin C and ascorbate) into all types of cells. Vitamin C is an essential nutrient that must be obtained through the diet and plasma levels are tightly regulated by transporter activity. Vitamin C plays an important role in antioxidant defenses and is a cofactor for many enzymes that enable hormone synthesis, oxygen sensing, collagen synthesis and epigenetic pathways. Although SVCT2 has various functions, regulation of its expression/activity remains poorly understood. We found a p53-binding site, within the SVCT2 promoter, using a transcription factor binding-site prediction tool. In this study, we show that p53 can directly repress SVCT2 transcription by binding a proximal- (~-185 to -171 bp) and a distal- (~-1800 to -1787 bp) p53-responsive element (PRE), Chromatin immunoprecipitation assays showed that PRE-bound p53 interacts with the corepressor-histone deacetylase 3 (HDAC3), resulting in deacetylation of histones Ac-H4, at the proximal promoter, resulting in transcriptional silencing of SVCT2. Overall, our data suggests that p53 is a potent transcriptional repressor of SVCT2, a critical transporter of diet-derived ascorbic acid, across the plasma membranes of numerous essential tissue cell types.

Entities:  

Keywords:  Biomarker; Corepressor; HDAC3; SVCT2; Vitamin C; p53; p53R175H

Mesh:

Substances:

Year:  2021        PMID: 33580460     DOI: 10.1007/s11033-021-06179-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  17 in total

1.  Structural basis of DNA recognition by p53 tetramers.

Authors:  Malka Kitayner; Haim Rozenberg; Naama Kessler; Dov Rabinovich; Lihi Shaulov; Tali E Haran; Zippora Shakked
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

Review 2.  Blinded by the Light: The Growing Complexity of p53.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

3.  Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

Authors:  M Murphy; J Ahn; K K Walker; W H Hoffman; R M Evans; A J Levine; D L George
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

4.  Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to transcriptional activation.

Authors:  Jitka Malcikova; Boris Tichy; Jiri Damborsky; Jitka Kabathova; Martin Trbusek; Jiri Mayer; Sarka Pospisilova
Journal:  Biol Chem       Date:  2010 Feb-Mar       Impact factor: 3.915

5.  A common gain of function of p53 cancer mutants in inducing genetic instability.

Authors:  D P Liu; H Song; Y Xu
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

6.  A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene.

Authors:  Dong-In Koh; Won-Il Choi; Bu-Nam Jeon; Choong-Eun Lee; Chae-Ok Yun; Man-Wook Hur
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

Review 7.  Cytoplasmic functions of the tumour suppressor p53.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

Review 8.  SVCT1 and SVCT2: key proteins for vitamin C uptake.

Authors:  I Savini; A Rossi; C Pierro; L Avigliano; M V Catani
Journal:  Amino Acids       Date:  2007-06-01       Impact factor: 3.520

Review 9.  Vitamin C Transporters in Cancer: Current Understanding and Gaps in Knowledge.

Authors:  Christina Wohlrab; Elisabeth Phillips; Gabi U Dachs
Journal:  Front Oncol       Date:  2017-04-24       Impact factor: 6.244

10.  Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression.

Authors:  Sungrae Cho; Jin Sung Chae; Hocheol Shin; Yujeong Shin; Haeun Song; Youngwook Kim; Byong Chul Yoo; Kangsan Roh; Seungchan Cho; Eui-Joon Kil; Hee-Seong Byun; Sang-Ho Cho; Seyeon Park; Sukchan Lee; Chang-Hwan Yeom
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.